|
|
|
|
|
|
INTERMEDIATES |
NO. |
PRODUCT
NAME |
|
41 |
2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone |
204205-33-4 |
42 |
Cyclopropyl 2-fluorobenzyl ketone |
150322-73-9 |
43 |
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic acid |
137281-39-1 |
44 |
(S)-(-)-1,2,3,4-Tetrahedro-naphthoic acid |
85977-52-2 |
45 |
3-Hydroxy-1-adamantyl-D-glycine |
709031-29-8 |
46 |
carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid |
361442-00-4 |
47 |
(1S,3S,5S)-3-(AMinocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester |
361440-67-7 |
48 |
(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide |
700376-57-4 |
49 |
Methyl (2R,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-3-phenylpropionate |
124605-42-1 |
50 |
7-Triethylsilyl-13-[(4S,5R)-3-(N-benzoyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine- 5-carbonyl] baccatinIII |
-- |
51 |
(3R,4S)-3-Hydroxy-4-phenyl-2-azetidinone |
132127-34-5 |
52 |
(aR,bS)-beta-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-hydroxy-benzenepropanoic acid |
114915-14-9 |
53 |
1,2,3-triacetoxy-5-deoxy-D-ribose |
62211-93-2 |
54 |
2',3'-Di-O-acetyl-5’-deoxy-5-fluorocytidine |
161599-46-8 |
55 |
3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]traazoli[4,3-1]pyrazine
hydrochloride |
486460-21-3 |
56 |
Imatinib |
152459-95-5 |
57 |
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic
acid |
137281-39-1 |
58 |
4(5)-Amino-5(4)-imidazolecarboxamide
hydrochloride |
72-40-2 |
59 |
(S)-(-)-1,2,3,4-Tetrahedro-naphthoic
acid |
85977-52-2 |
60 |
Methotrexate Disodium salt |
7413-34-5 |
Previous Next page
* The products under valid patents will not be offered to the
countries covered by the patents. |
|
|
|